Mendota Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-87
Closed -$9.13K 74
2025
Q4
$9.13K Hold
87
0.01% 90
2025
Q3
$7.28K Hold
87
0.01% 104
2025
Q2
$6.87K Hold
87
0.01% 84
2025
Q1
$7.79K Hold
87
0.01% 85
2024
Q4
$8.63K Sell
87
-5
-5% -$515 0.01% 245
2024
Q3
$10.4K Buy
92
+5
+6% +$594 0.01% 240
2024
Q2
$10.7K Sell
87
-58
-40% -$7.47K 0.01% 227
2024
Q1
$19.1K Buy
145
+1
+0.7% +$123 0.01% 218
2023
Q4
$15.7K Hold
144
0.01% 254
2023
Q3
$14.8K Buy
144
+1
+0.7% +$108 0.02% 180
2023
Q2
$16.5K Buy
143
+3
+2% +$341 0.02% 178
2023
Q1
$11.5K Sell
140
-2
-1% -$216 0.01% 220
2022
Q4
$15.7K Buy
+142
New +$14.5K 0.02% 188

Other funds holding MRK

Mendota Financial Group's MRK Position: Q1 2026 in Review

Mendota Financial Group sold out of Merck (MRK) in Q1 2026, closing a stake of 87 shares — an estimated $9.13K sold.

Mendota Financial Group first reported a position in MRK in Q4 2022 and held it in 13 quarters. The position peaked at $19.1K in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mendota Financial Group reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Mendota Financial Group sold 87 Merck shares in Q1 2026, an estimated $9.13K.
  • Mendota Financial Group first reported a position in Merck in Q4 2022 and held it in 13 quarters.
  • Mendota Financial Group's Merck position peaked at $19.1K in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mendota Financial Group's 13F filing for Q1 2026, filed 16 Apr 2026.